Diabetes Care

Christine Ferrara-Cook, Susan Michelle Geyer, Carmella Evans-Molina, Ingrid M Libman, Dorothy J Becker, Stephen E Gitelman, Maria Jose Redondo
OBJECTIVE: Sustained excess BMI increases the risk of type 1 diabetes (T1D) in autoantibody-positive relatives without diabetes of patients. We tested whether elevated BMI also accelerates the progression of islet autoimmunity before T1D diagnosis. RESEARCH DESIGN AND METHODS: We studied 706 single autoantibody-positive pediatric TrialNet participants (ages 1.6-18.6 years at baseline). Cumulative excess BMI (ceBMI) was calculated for each participant based on longitudinally accumulated BMI ≥85th age- and sex-adjusted percentile...
January 14, 2020: Diabetes Care
Christine L Chan, Andrea K Steck, Cameron Severn, Laura Pyle, Marian Rewers, Philip S Zeitler
No abstract text is available yet for this article.
January 14, 2020: Diabetes Care
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, Yogish C Kudva, Lori M Laffel, Carol Levy, Jordan E Pinsker, R Paul Wadwa, Bruce Buckingham, Francis J Doyle, Sue A Brown, Mei Mei Church, Vikash Dadlani, Eyal Dassau, Laya Ekhlaspour, Gregory P Forlenza, Elvira Isganaitis, David W Lam, John Lum, Roy W Beck
OBJECTIVE: Assess the efficacy of inControl AP: a mobile closed-loop control (CLC) system. RESEARCH DESIGN AND METHODS: This protocol, NCT02985866, is a 3-month parallel group, multicenter, randomized unblinded trial designed to compare mobile CLC with sensor augmented pump (SAP) therapy. Eligibility criteria were type 1 diabetes for at least 1 year, use of insulin pumps for at least 6 months, age ≥14 years, and baseline HbA1c <10.5% (91 mmol/mol). The study was designed to assess two coprimary outcomes: superiority of CLC over SAP in continuous glucose monitor (CGM)-measured time below 3...
January 14, 2020: Diabetes Care
Brian C Callaghan, Evan L Reynolds, Mousumi Banerjee, Ericka Chant, Emily Villegas-Umana, Thomas W Gardner, Kristen Votruba, Bruno Giordani, Rodica Pop-Busui, Subramaniam Pennathur, Eva L Feldman
OBJECTIVE: To determine the prevalence of cognitive deficits and traditional diabetic complications and the association between metabolic factors and these outcomes. RESEARCH DESIGN AND METHODS: We performed a cross-sectional study in severely obese individuals before bariatric surgery. Lean control subjects were recruited from a research website. Cognitive deficits were defined by the National Institutes of Health (NIH) Toolbox (less than the fifth percentile for lean control subjects)...
January 13, 2020: Diabetes Care
Pernille Svalastoga, Åsta Sulen, Jarle R Fehn, Stein M Aukland, Henrik Irgens, Eivind Sirnes, Silje K E Fevang, Eivind Valen, Irene B Elgen, Pål R Njølstad
OBJECTIVE: Neonatal diabetes has been shown to be associated with high neuropsychiatric morbidity in a genotype-phenotype-dependent manner. However, the specific impact of different mutations on intellectual functioning is still insufficiently characterized. Specifically, only a small number of subjects with developmental delay have been comprehensively assessed, creating a knowledge gap for patients carrying the heaviest burden. RESEARCH DESIGN AND METHOD: We here assessed the intellectual functioning and mental health of the complete Norwegian population of KATP channel neonatal diabetes...
January 13, 2020: Diabetes Care
Jerome Carayol, Joanne Hosking, Jonathan Pinkney, Julien Marquis, Aline Charpagne, Sylviane Metairon, Alison Jeffery, Jörg Hager, Francois-Pierre Martin
OBJECTIVE: Previous studies suggested that childhood prediabetes might develop prior to obesity and be associated with relative insulin deficiency. We proposed that the insulin-deficient phenotype is genetically determined and tested this hypothesis by longitudinal modeling of insulin and glucose traits with diabetes risk genotypes in the EarlyBird cohort. RESEARCH DESIGN AND METHODS: EarlyBird is a nonintervention prospective cohort study that recruited 307 healthy U...
January 8, 2020: Diabetes Care
Clemens Wittenbecher, Tamara Štambuk, Olga Kuxhaus, Najda Rudman, Frano Vučković, Jerko Štambuk, Catarina Schiborn, Dario Rahelić, Stefan Dietrich, Olga Gornik, Markus Perola, Heiner Boeing, Matthias B Schulze, Gordan Lauc
OBJECTIVE: Plasma protein N -glycan profiling integrates information on enzymatic protein glycosylation, which is a highly controlled ubiquitous posttranslational modification. Here we investigate the ability of the plasma N -glycome to predict incidence of type 2 diabetes and cardiovascular diseases (CVDs; i.e., myocardial infarction and stroke). RESEARCH DESIGN AND METHODS: Based on the prospective European Prospective Investigation of Cancer (EPIC)-Potsdam cohort ( n = 27,548), we constructed case-cohorts including a random subsample of 2,500 participants and all physician-verified incident cases of type 2 diabetes ( n = 820; median follow-up time 6...
January 8, 2020: Diabetes Care
Xiang Liu, Kendra Vehik, Yangxin Huang, Helena Elding Larsson, Jorma Toppari, Anette G Ziegler, Jin-Xiong She, Marian Rewers, William A Hagopian, Beena Akolkar, Jeffrey P Krischer
OBJECTIVE: This study investigates two-phase growth patterns in early life and their association with development of islet autoimmunity (IA) and type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: The Environmental Determinants of Diabetes in the Young (TEDDY) study followed 7,522 genetically high-risk children in Sweden, Finland, Germany, and the U.S. from birth for a median of 9.0 (interquartile range 5.7-10.6) years with available growth data. Of these, 761 (10...
January 2, 2020: Diabetes Care
Nasui Wang, Alvin W K Tan, Linda A Jahn, Lee Hartline, James T Patrie, Shaoda Lin, Eugene J Barrett, Kevin W Aylor, Zhenqi Liu
OBJECTIVE: Obesity is associated with microvascular insulin resistance, which is characterized by impaired insulin-mediated microvascular recruitment. Glucagon-like peptide 1 (GLP-1) recruits skeletal and cardiac muscle microvasculature, and this action is preserved in insulin-resistant rodents. We aimed to examine whether GLP-1 recruits microvasculature and improves the action of insulin in obese humans. RESEARCH DESIGN AND METHODS: Fifteen obese adults received intravenous infusion of either saline or GLP-1 (1...
December 30, 2019: Diabetes Care
Mary E Lacy, Paola Gilsanz, Chloe Eng, Michal S Beeri, Andrew J Karter, Rachel A Whitmer
OBJECTIVE: In children with type 1 diabetes (T1D), severe hypoglycemia (SH) is associated with poorer cognition, but the association of SH with cognitive function in late life is unknown. Given the increasing life expectancy in T1D, understanding the role of SH in brain health is crucial. RESEARCH DESIGN AND METHODS: We examined the association between SH and cognitive function in 718 older adults with T1D from the Study of Longevity in Diabetes (SOLID). Subjects self-reported recent SH (previous 12 months) and lifetime history of SH resulting in inpatient/emergency department utilization...
December 27, 2019: Diabetes Care
Eberhard Standl, Susanna R Stevens, Yuliya Lokhnygina, M Angelyn Bethel, John B Buse, Stephanie M Gustavson, Aldo P Maggioni, Robert J Mentz, Adrian F Hernandez, Rury R Holman
OBJECTIVE: We sought to confirm a bidirectional association between severe hypoglycemic events (SHEs) and cardiovascular (CV) event risk and to characterize individuals at dual risk. RESEARCH DESIGN AND METHODS: In a post hoc analysis of 14,752 Exenatide Study of Cardiovascular Event Lowering (EXSCEL) participants, we examined time-dependent associations between SHEs and subsequent major adverse cardiac events (CV death, nonfatal myocardial infarction [MI] or stroke), fatal/nonfatal MI, fatal/nonfatal stroke, hospitalization for acute coronary syndrome (hACS), hospitalization for heart failure (hHF), and all-cause mortality (ACM), as well as time-dependent associations between nonfatal CV events and subsequent SHEs...
December 27, 2019: Diabetes Care
Sung Eun Choi, Corneliu Sima, Ankur Pandya
OBJECTIVE: Previous randomized trials found that treating periodontitis improved glycemic control in patients with type 2 diabetes (T2D), thus lowering the risks of developing T2D-related microvascular diseases and cardiovascular disease (CVD). Some payers in the U.S. have started covering nonsurgical periodontal treatment for those with chronic conditions, such as diabetes. We sought to identify the cost-effectiveness of expanding periodontal treatment coverage among patients with T2D...
December 27, 2019: Diabetes Care
Kevin A Peterson, Caroline Carlin, Leif I Solberg, Rachel Jacobsen, Toni Kriel, Milton Eder
OBJECTIVE: The effective redesign of primary care delivery systems to improve diabetes care requires an understanding of which particular components of delivery consistently lead to better clinical outcomes. We identified associations between common systems of care management (SysCMs) and the frequency of meeting standardized performance targets for Optimal Diabetes Care (NQF#0729) in primary care practices. RESEARCH DESIGN AND METHODS: A validated survey of 585 eligible family or general internal medicine practices seeing ≥30 adult patients with diabetes in or near Minnesota during 2017 evaluated the presence of 62 SysCMs...
December 27, 2019: Diabetes Care
Karin Littmann, Tigist Wodaje, Michael Alvarsson, Matteo Bottai, Mats Eriksson, Paolo Parini, Jonas Brinck
OBJECTIVE: To investigate the association of the cardiovascular risk factor Lipoprotein(a) [Lp (a)] and vascular complications in patients with type 1 diabetes mellitus. RESEARCH DESIGN AND METHODS: Patients with type 1 diabetes mellitus receiving regular care were recruited in this observational cross-sectional study and divided into four groups according to their Lp(a) levels in nmol/L (Very Low <10; Low 10-30; Intermediate 30-120; High>120). Prevalence of vascular complications was compared between the groups...
December 20, 2019: Diabetes Care
Jian-Jun Liu, Sylvia Liu, Pierre-Jean Saulnier, Elise Gand, Robin W M Choo, Resham L Gurung, Samy Hadjadj, Su Chi Lim
OBJECTIVE: Haptoglobin is an acute-phase reactant with pleiotropic functions. We aim to study whether urine haptoglobin may predict risk of mortality in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We employed a transethnic approach with a cohort of Asian origin (Singapore) ( N = 2,061) and a cohort of European origin (France) ( N = 1,438) included in the study. We used survival analyses to study the association of urine haptoglobin with risk of all-cause and cause-specific mortality...
December 20, 2019: Diabetes Care
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies
The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials published in 2019. Important changes include: 1 ) the decision to treat high-risk individuals with a glucagon-like peptide 1 (GLP-1) receptor agonist or sodium-glucose cotransporter 2 (SGLT2) inhibitor to reduce major adverse cardiovascular events (MACE), hospitalization for heart failure (hHF), cardiovascular death, or chronic kidney disease (CKD) progression should be considered independently of baseline HbA1c or individualized HbA1c target; 2 ) GLP-1 receptor agonists can also be considered in patients with type 2 diabetes without established cardiovascular disease (CVD) but with the presence of specific indicators of high risk; and 3 ) SGLT2 inhibitors are recommended in patients with type 2 diabetes and heart failure, particularly those with heart failure with reduced ejection fraction, to reduce hHF, MACE, and CVD death, as well as in patients with type 2 diabetes with CKD (estimated glomerular filtration rate 30 to ≤60 mL min-1 [1...
December 19, 2019: Diabetes Care
Stephan R Lindner, Miguel Marino, Jean O'Malley, Heather Angier, Steffani R Bailey, Megan Hoopes, Rachel Springer, K John McConnell, Jennifer DeVoe, Nathalie Huguet
OBJECTIVE: To compare trends in Medicaid expenditures among adults with diabetes who were newly eligible due to the Affordable Care Act (ACA) Medicaid expansion to those previously eligible. RESEARCH DESIGN AND METHODS: This is a retrospective cohort study from 1 January 2014 to 30 September 2016 with propensity score-matched Medicaid eligibility groups (newly and previously eligible). Outcome measures included total per-member per-month (PMPM) Medicaid expenditures, and PMPM expenditures in the following 12 categories: inpatient visits, emergency department visits, primary care physician visits, specialist visits, prescription drugs, transportation services, tests, imaging and echography, procedures, durable medical equipment, evaluation and management, and other or unknown services...
December 19, 2019: Diabetes Care
Claire Welsh, Paul Welsh, Carlos A Celis-Morales, Patrick B Mark, Daniel Mackay, Nazim Ghouri, Fredrick K Ho, Lyn D Ferguson, Rosemary Brown, James Lewsey, John G Cleland, Stuart R Gray, Donald M Lyall, Jana J Anderson, Pardeep S Jhund, Jill P Pell, Darren K McGuire, Jason M R Gill, Naveed Sattar
OBJECTIVE: HbA1c levels are increasingly measured in screening for diabetes; we investigated whether HbA1c may simultaneously improve cardiovascular disease (CVD) risk assessment, using QRISK3, American College of Cardiology/American Heart Association (ACC/AHA), and Systematic COronary Risk Evaluation (SCORE) scoring systems. RESEARCH DESIGN AND METHODS: UK Biobank participants without baseline CVD or known diabetes ( n = 357,833) were included. Associations of HbA1c with CVD was assessed using Cox models adjusting for classical risk factors...
December 18, 2019: Diabetes Care
Angelo Avogaro, Gian Paolo Fadini, Stefano Del Prato
Cardiovascular outcome trials have provided evidence that sodium-glucose cotransporter 2 inhibitor (SGLT2i) treatment is associated with remarkably favorable cardiovascular outcomes. Here, we offer a novel hypothesis that may encompass many of these hypothetical mechanisms, i.e., the ability of SGLT2i to modify the trajectory of cell response to a toxic environment through modifications of cellular life history programs, either the defense program or the dormancy program. The choice between these programs is mainly determined by the environment...
December 16, 2019: Diabetes Care
Marie-Eve Robinson, Marc Simard, Isabelle Larocque, Jai Shah, Meranda Nakhla, Elham Rahme
OBJECTIVE: To determine the longitudinal risks of psychiatric disorders in adolescents and emerging adults with versus without diabetes. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study in Quebec, Canada, using linked health administrative databases of adolescents (age 15 years) with and without diabetes and without prior psychiatric disorders between 1997 and 2015, followed to age 25 years. RESULTS: Our cohort included 3,544 individuals with diabetes and 1,388,397 without diabetes...
December 16, 2019: Diabetes Care
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"